Sysmex

Oxford Immunotec said recent trial data suggest that individuals with SARS-CoV-2 specific T cells but without detectible antibodies may be protected from infection.

The system, which automates the process of performing blood cell differentials, was cleared by the US Food and Drug Administration last month.

The chemiluminescence enzyme immunoassay is designed to detect SARS-CoV-2 antigens in nasopharyngeal and nasal swab samples.

The Japanese diagnostics developer attributed the revenue decline to the impact of the ongoing SARS-CoV-2 pandemic on both domestic and international sales.

The Clinitek Novus Automated Urine Analyzer uses dry-pad urine chemistry technology and a cassette test format to provide a variety of chemistry strip tests.

The company said it will look to obtain regulatory approval in additional countries to accelerate the analyzer's market introduction in Asia and Africa.

News items for the in vitro diagnostics industry for the week of June 29, 2020.

To enable the use of saliva in addition to other types of samples, Sysmex requested a change to a marketing approval it obtained in March.

Sysmex anticipates delivering the kit to Japanese medical institutions this month for diagnosis of the SARS-CoV-2 infection.

Contributing to the Japanese diagnostic firm's higher revenues were increased instrument and reagent sales both domestically and internationally.